Banque Cantonale Vaudoise 10x Genomics, Inc. Transaction History

Banque Cantonale Vaudoise

  • $2.52 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 10, 2024
SELL
$36.08 - $54.3 $121,192 - $182,393
-3,359 Reduced 28.56%
8,404 $315,000
Q4 2023

Feb 07, 2024
SELL
$34.32 - $57.55 $81,166 - $136,105
-2,365 Reduced 16.74%
11,763 $658,000
Q3 2023

Nov 08, 2023
SELL
$40.86 - $62.98 $7,395 - $11,399
-181 Reduced 1.26%
14,128 $583,000
Q2 2023

Aug 09, 2023
BUY
$50.96 - $58.72 $729,186 - $840,224
14,309 New
14,309 $799,000

Others Institutions Holding TXG

# of Institutions
284
Shares Held
96.2M
Call Options Held
162K
Put Options Held
107K
View Full List

About 10x Genomics, Inc.

TXG Quotes by TradingView
  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.91B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Banque Cantonale Vaudoise Portfolio

Follow Banque Cantonale Vaudoise and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

News

Stay updated on Banque Cantonale Vaudoise with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email